We are live on
!
Find out more
CT
Cambridge Trust Portfolio holdings
AUM
$2.64B
Turnover
15.41%
1-Year Est. Return
28.73%
This Fund
S&P 500
This Quarter
Est. Return
+3.33%
1 Year Est. Return
+28.73%
3 Year Est. Return
+42.93%
5 Year Est. Return
+123.28%
10 Year Est. Return
+319.24%
AUM
$1.42B
AUM Growth
+$53.3M
(+3.9%)
Cap. Flow
+$29.9M
Cap. Flow
% of AUM
2.1%
Top 10 Holdings %
Top 10 Hldgs %
26.02%
Holding
276
New
21
Increased
128
Reduced
73
Closed
13
Avg Time Held
2.2
years
Top 10 Avg Time Held
1.9
years
Top 20 Avg Time Held
1.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$6.96M |
| 2 |
Merck
MRK
|
+$6.29M |
| 3 |
UnitedHealth
UNH
|
+$5.85M |
| 4 |
Amazon
AMZN
|
+$5.11M |
| 5 |
Meta Platforms (Facebook)
META
|
+$4.86M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$11.9M |
| 2 |
Cardinal Health
CAH
|
+$9.07M |
| 3 |
AT&T
T
|
+$3.98M |
| 4 |
Medtronic
MDT
|
+$3.36M |
| 5 |
Estee Lauder
EL
|
+$2.92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.84% |
| 2 | Healthcare | 14.41% |
| 3 | Technology | 13.82% |
| 4 | Industrials | 11.14% |
| 5 | Energy | 9.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Amphenol
APH
$199B
| $538K | 0.04% |
64,000
| – | – |
2016 Q2
2 quarters
|
|
177
iShares S&P 500 Growth ETF
IVW
$77.7B
| $522K | 0.04% |
17,140
+2,252
| +15% | +$68K |
2015 Q4
4 quarters
|
|
178
Agilent Technologies
A
$49.3B
| $517K | 0.04% |
11,348
+1,831
| +19% | +$83.1K |
2015 Q4
4 quarters
|
|
179
Costco
COST
$437B
| $487K | 0.03% |
3,044
-23
| -0.7% | -$3.51K |
2014 Q3
9 quarters
|
|
180
Fomento Económico Mexicano
FMX
$43.1B
| $487K | 0.03% |
6,390
-274
| -4% | -$23.5K |
2014 Q2
10 quarters
|
|
181
Martin Marietta Materials
MLM
$35.9B
| $480K | 0.03% |
2,165
+11
| +0.5% | +$2.26K |
2014 Q3
9 quarters
|
|
182
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.87B
| $470K | 0.03% |
22,392
+2,965
| +15% | +$62.6K |
2013 Q2
14 quarters
|
|
183
General Dynamics
GD
$93.1B
| $470K | 0.03% |
2,720
+1,225
| +82% | +$200K |
2015 Q2
6 quarters
|
|
184
Sysco
SYY
$40.6B
| $467K | 0.03% |
8,429
+3,300
| +64% | +$171K |
2013 Q2
14 quarters
|
|
185
Alerian MLP ETF
AMLP
$12.6B
| $460K | 0.03% |
7,307
| – | – |
2013 Q2
14 quarters
|
|
186
Unilever
UL
$142B
| $457K | 0.03% |
9,990
+1,666
| +20% | +$77.7K |
2016 Q2
2 quarters
|
|
187
Cintas
CTAS
$85.4B
| $447K | 0.03% |
15,460
+2,040
| +15% | +$57.3K |
2015 Q3
5 quarters
|
|
188
iShares Russell 2000 ETF
IWM
$77.3B
| $444K | 0.03% |
3,292
+118
| +4% | +$15.1K |
2013 Q2
14 quarters
|
|
189
Southern Company
SO
$104B
| $436K | 0.03% |
8,859
| – | – |
2013 Q2
14 quarters
|
|
190
Eli Lilly
LLY
$1.13T
| $426K | 0.03% |
5,790
+11
| +0.2% | +$819 |
2014 Q1
11 quarters
|
|
191
Saic
SAIC
$5.63B
| $424K | 0.03% |
5,000
| – | – |
2016 Q2
2 quarters
|
|
192
Marsh
MRSH
$89.6B
| $422K | 0.03% |
6,245
+675
| +12% | +$45.3K |
2015 Q2
6 quarters
|
|
193
W.W. Grainger
GWW
$63B
| $418K | 0.03% |
1,800
| – | – |
2013 Q2
14 quarters
|
|
194
T. Rowe Price
TROW
$21.7B
| $411K | 0.03% |
5,460
-360
| -6% | -$25.5K |
2015 Q4
4 quarters
|
|
195
Norwegian Cruise Line
NCLH
$7.15B
| $406K | 0.03% |
9,551
+4,071
| +74% | +$163K |
2016 Q3
1 quarter
|
|
196
iShares Gold Trust
IAU
$62.1B
| – | – |
0
| – | – |
2015 Q2
6 quarters
|
|
197
Range Resources
RRC
$9.87B
| $402K | 0.03% |
11,712
+293
| +3% | +$10.5K |
2013 Q2
14 quarters
|
|
198
Deere & Co
DE
$175B
| $386K | 0.03% |
3,749
+100
| +3% | +$9.4K |
2013 Q2
14 quarters
|
|
|
AET
199
DELISTED
Aetna Inc
AET
| $384K | 0.03% |
3,097
-110
| -3% | -$13.2K |
2014 Q1
11 quarters
|
|
200
Tompkins Financial
TMP
$1.41B
| $379K | 0.03% |
4,005
-38
| -0.9% | -$3.18K |
2013 Q2
14 quarters
|
|
Similar funds
ZCM
CQS
SCM
AFIMH
DA
Cambridge Trust's Q4 2016 Portfolio in Review
As of Q4 2016, Cambridge Trust held 276 positions worth $1.42B, up 3.9% from $1.37B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Cambridge Trust's Q4 2016 filing shows 21 new, 128 increased, 73 reduced and 13 closed positions. Its largest new stake was State Street Consumer Staples Select Sector SPDR ETF: 38,120 shares worth $1.97M. The largest sale was Novartis, an estimated $11.9M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.
- Cambridge Trust's largest Q4 2016 buy was State Street Consumer Staples Select Sector SPDR ETF: 38,120 shares worth $1.97M.
- Cambridge Trust added most to Celgene Corp in Q4 2016, an estimated $6.96M increase.
- Cambridge Trust's biggest Q4 2016 reduction was Novartis, cutting an estimated $11.9M.
- Cambridge Trust fully exited Cardinal Health in Q4 2016, selling an estimated $9.07M.
- Cambridge Trust's ten largest holdings make up 26% of its $1.42B portfolio in Q4 2016.
- Cambridge Trust opened 21 new positions and closed 13 in Q4 2016.
- Cambridge Trust's portfolio value rose 3.9% quarter-over-quarter to $1.42B.
Based on Cambridge Trust's 13F filing for Q4 2016, filed 3 Feb 2017.